National and Kapodistrian University of Athens
Προοπτική μελέτη των επιπέδων ορού της NGAL, MMP-9 και των αγγειογεννητικών μορίων PIGF και sFLT-1 σε εγκύους με υπερτασική νόσο
Abstract
dc:descriptionAim of the study: Preeclampsia is a systematic disease of pregnancy characterized by hypertension and proteinouria developing after the 20th week of pregnancy. Several new studies have shown that the blood serum levels of circulating NGAL are seriously altered in preeclamptic pregnancies and their measurement in maternal serum may be useful in screening and/or diagnosis of patients at high risk of developing preeclampsia. The purposes of our study were initially to explore the levels and the possible pathophysiological role of NGAL, MMP-9, their complex (MMP-9/NGAL), PLGF and sFLT-1 in normal and preeclamptic pregnancies and then to evaluate their significance as specific diagnostic markers in the prediction of the disease. Patients and Methods: In 95 pregnant women [69 normal, 12 pregnancies that developed preeclampsia and 14 with SGA (small for gestational age) fetuses] we determined the serum concentrations of NGAL, MMP-9, MMP-9/NGAL complex, PLGF and sFLT-1 in the first (11+1 to 13+6 weeks), second (20+1 to 24+0 weeks) and third (28+1 – 34+0 weeks) trimester of pregnancy. Serum concentrations of NGAL, MMP-9 and MMP-9/NGAL complex were determined with commercially available kits: Human Lipocalin-2/NGAL Quantikine ELISA Kit, Human Matrix Metalloproteinase-9/MMP-9 Quantikine ELISA Kit and Human MMP-9/NGAL Complex Quantikine ELISA Kit, R&D SYSTEMS. Results: Median serum concentrations (ng/ml) and interquartile range (IQR) of NGAL in normal pregnancies were: 12.8 (8 - 21.1); 25.9 (14.7 – 34.6) and 48 (22.7 – 78.6) ng/mL in the three trimesters of pregnancy respectively. NGAL serum concentrations(ng/ml) in pregnancies that developed preeclampsia were significantly different from normal in the 1st and 2nd trimester but not in the 3rd [30.9 (21 – 52.3)/p=0,006; 44.6 (35.7 – 71.8) p=0,015; 87.6 (43.5 – 115.6)/ p=0,174 in the three trimesters respectively]. On the contrary, MMP-9 and MMP-9/NGAL complex serum concentrations in pregnancies that developed preeclampsia didn’t differ significantly between normal and preeclamptic pregnancies in any trimester. Additionally, women with SGA fetuses had no significantly different NGAL, MMP-9 and MMP-9/NGAL complex serum concentrations in any trimester compared to normal or pre-eclamptic pregnancies. Finally, PLGF serum concentrations (pg/ml) were statistically different between normal and preeclamptic pregnancies in the 2nd and in the 3rd (p=0.019 and p<0.001 respectively) but not in the 1st trimester, while those of sFLT-1 (pg/ml) were different only in the 3rd trimester (p=0.011).Conclusion: According to our findings serum concentrations of NGAL, MMP-9, MMP-9/NGAL and PLGF in normal pregnancies were significantly different between the 1st and the 3rd, trimester increasing as the pregnancy develops. In pregnancies that developed preeclampsia, statistically significant difference in NGAL, MMP-9, MMP-9/NGAL complex, PLGF and sFLT-1 serum concentrations was found between 1st and 3rd trimesters. The most important finding of our study is the fact that NGAL levels in pregnancies with preeclampsia were significantly different than those in normal pregnancies in the 1st and 2nd but not in the 3rd trimester (p=0,006 for 1st trim; p=0,015 for 2nd trim; p=0,174 for 3rd trim). Finally NGAL, MMP-9, MMP-9/NGAL complex and PLGF serum concentrations in pregnancies that developed preeclampsia didn’t differ significantly from concentrations in normal or pregnancies with SGA fetuses in any trimester.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karampas, Grigorios
- Καραμπάς, Γρηγόριος
Subjects
dc:subject × 32- Πρώιμη ανίχνευση προεκλαμψίας
- Προεκλαμψία πρώϊμης έναρξης
- Βιοχημικοί προγνωστικοί δείκτες
- Κύηση υψηλού κινδύνου (Σακχ. διαβήτη, υπέρταση)
- Υψηλού κινδύνου κύηση
- Παθολογική κύηση
- Β' τρίμηνο κύησης
- Επιπλεγμένη κύηση
- Επιπλοκές κύησης
- Λευκωματουρία κύησης
- Υπέρταση κυήσεως
- Preeclasmpsia
- Preeclampsia placenta
- Early detection of preeclampsia
- Early onset preeclampsia
- Hypertension in pregnancy
- Predictive biomarkers
- Prognostic biomarkers
- Prognostic molecular biomarkers
- Combination of biomarkers
- Circulating biomarkers
- Biomark
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μαιευτική και Γυναικολογία
- Βασική Ιατρική
- Ιατρική βιοχημεία
- Clinical Medicine
- Medical and Health Sciences
- Obstetrics and Gynecology
- Basic Medicine
- Medical Biochemistry
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55778